Amarin to Report Third Quarter 2022 Financial Results And Host Conference Call on October 27, 2022
Amarin Corporation plc (NASDAQ:AMRN) will host a conference call on October 27, 2022, at 8:00 a.m. ET to discuss its third quarter 2022 financial results. The call follows the pre-market release of the financial results. Interested parties can access the live call through the investor relations section of Amarin's website or via dial-in options provided for both U.S. and international participants. A replay of the call will also be available after the event through the website.
- None.
- None.
DUBLIN, Ireland and BRIDGEWATER, N.J., Oct. 20, 2022 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that it will host a conference call with members of Amarin’s senior management team to discuss the Company’s third quarter 2022 financial results on Thursday, October 27th, 2022 at 8:00 a.m. ET.
The conference call with management will follow the release of the Company’s third quarter 2022 financial results in the pre-market hours.
Conference Call and Webcast Information:
Access to the live call:
Go to the investor relations section of the Company’s website at www.amarincorp.com
Dial in within the United States: 888-506-0062
International dial in: 973-528-0011
Access Code: 367970
Access to replay:
Dial in within the United States: 877-481-4010
International dial in:919-882-2331
Access Code: 46629
A replay of the call will also be available through the Company’s website shortly after the call.
About Amarin
Amarin is an innovative pharmaceutical company leading a new paradigm in cardiovascular disease management. From our foundation in scientific research to our focus on clinical trials, and now our commercial expansion, we are evolving and growing rapidly. Amarin has offices in Bridgewater, New Jersey in the United States, Dublin in Ireland, Zug in Switzerland, and other countries in Europe as well as commercial partners and suppliers around the world. We are committed to increasing the scientific understanding of the cardiovascular risk that persists beyond traditional therapies and advancing the treatment of that risk.
Availability of Other Information About Amarin
Amarin communicates with its investors and the public using the company website (www.amarincorp.com) and the investor relations website (investor.amarincorp.com), including but not limited to investor presentations and FAQs, Securities and Exchange Commission filings, press releases, public conference calls and webcasts. The information that Amarin posts on these channels and websites could be deemed to be material information. As a result, Amarin encourages investors, the media and others interested in Amarin to review the information that is posted on these channels, including the investor relations website, on a regular basis. This list of channels may be updated from time to time on Amarin’s investor relations website and may include social media channels. The contents of Amarin’s website or these channels, or any other website that may be accessed from its website or these channels, shall not be deemed incorporated by reference in any filing under the Securities Act of 1933.
Amarin Contact Information
Investor Inquiries:
Lisa DeFrancesco
Amarin Corporation plc
Media Inquiries:
Mark Marmur
Amarin Corporation plc
FAQ
When will Amarin Corporation announce its third quarter 2022 financial results?
How can I listen to Amarin's conference call for Q3 2022?
What time is Amarin's third quarter 2022 conference call?
Is there a replay available for Amarin's Q3 2022 conference call?
